サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1726219

アルボウイルス検査の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Arbovirus Testing Market Size, Share & Trends Analysis Report By Type (ELISA-Based Tests, RT-PCR Based Tests), By End-use (Diagnostic Laboratories, Hospitals, Research Centers), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 110 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
アルボウイルス検査の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年04月11日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アルボウイルス検査の市場規模と動向

世界のアルボウイルス検査市場規模は2024年に11億2,000万米ドルとなり、2025～2030年にかけてCAGR 4.5%で成長すると予測されています。

ジカ熱、デング熱、西ナイルなどのアルボウイルス疾患の発生率が上昇していることが、堅牢な検査ソリューションの需要を促進しています。様々な地域でこれらの疾患の流行が増加しているため、アウトブレイクを効果的に管理するための正確な診断の必要性が高まっています。一般市民やヘルスケアシステムにおける意識の高まりは、サーベイランス活動の改善につながり、潜在的なアウトブレイクに対する迅速な特定と対応を可能にしています。

政府や医療機関は、これらの感染症の蔓延を抑制するためにタイムリーな検出を優先しているためです。

アルボウイルス検査は、顧みられない熱帯病（Neglected Tropical Diseases：NTDs）の蔓延を防ぐための極めて重要なツールとして浮上しています。WHOの推定によると、人口の約5分の1、約17億人が、主に発展途上国や低所得国で、毎年少なくとも1つの非感染性疾患の診断と治療を受けなければならないです。デング熱とチクングニアのNTDの流行は、アフリカのほぼ40％に影響を及ぼしています。これらの病気は、ウィルスの増殖に適した環境と不衛生な環境のため、熱帯地域や手の届きにくい場所にある貧困地域で多く見られます。そのため、NTDの症例のほとんどは、ブラジル、イエメン、インド、バングラデシュ、中国、中央アフリカと東アフリカの数カ国から報告されています。したがって、デング熱とチクングニヤの発生率の増加は、アルボウイルス検査の需要を煽り、市場の成長を促進すると予想されます。

さらに、米国世界ヘルスイニシアチブ、疾病対策予防センターによる世界NTDプログラム、世界保健機関の世界NTDプログラム、米国国際開発庁によるNTDプログラムなど、複数の国際機関がNTDに対する認識を高めるためのプログラムを実施しています。これらのプログラムは、主にデング熱やチクングニアなどのNTDsを削減または撲滅することに重点を置いています。さらに、WHOは2023年10月に、NTDsのためのWHO診断薬専門家審査パネル（ERPD）のパイロットプログラムを導入しました。このプログラムは、医療従事者向けのNTD診断ツールの品質管理と入手可能性を高めることに重点を置いています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 アルボウイルス検査市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • アルボウイルス検査市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 アルボウイルス検査市場：タイプ別、推定・動向分析

  • タイプセグメントダッシュボード
  • アルボウイルス検査市場：タイプ変動分析
  • 世界のアルボウイルス検査市場規模と動向分析（タイプ別、2018～2030年）
  • ELISAベースの検査
  • RT-PCRベースの検査
  • その他の検査タイプ

第5章 アルボウイルス検査市場：最終用途別、推定・動向分析

  • 最終用途セグメントダッシュボード
  • アルボウイルス検査市場：最終用途変動分析
  • 世界のアルボウイルス検査市場規模と動向分析（最終用途別、2018～2030年）
  • 診断ラボ
  • 病院
  • 研究センター
  • その他

第6章 アルボウイルス検査市場：地域別、推定・動向分析

  • 地域別市場ダッシュボード
  • 地域別市場シェア分析、2024年と2030年
  • 地域別アルボウイルス検査市場：主要ポイント
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業ヒートマップ分析、2024年
  • 企業プロファイル
    • Abbott
    • Thermo Fisher Scientific Inc.
    • NovaTec Immundiagnostica GmbH（Gold Standard Diagnostics Frankfurt GmbH）
    • Agilent Technologies, Inc.
    • EUROIMMUN Medical Laboratory Diagnostics AG
    • Merck KGaA
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • QIAGEN
    • Bio-Rad Laboratories, Inc.
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Arbovirus Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 4. Global Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 5. Global Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6. North America Arbovirus Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 7. North America Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 8. North America Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9. U.S. Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 10. U.S. Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 11. Canada Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 12. Canada Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13. Mexico Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 14. Mexico Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15. Europe Arbovirus Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 16. Europe Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 17. Europe Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 18. Germany Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 19. Germany Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20. U.K. Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 21. U.K. Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 22. France Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 23. France Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24. Italy Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 25. Italy Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 26. Spain Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 27. Spain Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 28. Denmark Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 29. Denmark Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30. Sweden Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 31. Sweden Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 32. Norway Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 33. Norway Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Arbovirus Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37. Japan Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 38. Japan Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 39. China Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 40. China Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41. India Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 42. India Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 43. South Korea Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 44. South Korea Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45. Australia Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 46. Australia Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 47. Thailand Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 48. Thailand Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 49. Latin America Arbovirus Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 50. Latin America Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 51. Latin America Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 52. Brazil Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 53. Brazil Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54. Argentina Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 55. Argentina Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Arbovirus Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 59. South Africa Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 60. South Africa Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 63. UAE Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 64. UAE Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Arbovirus Testing Market: Market Outlook
  • Fig. 10 Arbovirus Testing Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Arbovirus Testing Market Driver Impact
  • Fig. 16 Arbovirus Testing Market Restraint Impact
  • Fig. 17 Arbovirus Testing Market Strategic Initiatives Analysis
  • Fig. 18 Arbovirus Testing Market: Type Movement Analysis
  • Fig. 19 Arbovirus Testing Market: Type Outlook and Key Takeaways
  • Fig. 20 ELISA-Based Tests Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 RT-PCR Based Tests Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Other Test Types Market Estimates and Forecast, 2018 - 2030
  • Fig. 23 Arbovirus Testing Market: End Use Movement Analysis
  • Fig. 24 Arbovirus Testing Market: End Use Outlook and Key Takeaways
  • Fig. 25 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • Fig. 26 Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 27 Research Centers Market, 2018 - 2030 (USD Million)
  • Fig. 28 Other End Use Market, 2018 - 2030 (USD Million)
  • Fig. 29 Global Arbovirus Testing Market: Regional Movement Analysis
  • Fig. 30 Global Arbovirus Testing Market: Regional Outlook and Key Takeaways
  • Fig. 31 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 32 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 33 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 U.K. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Kuwait Market Estimates and Forecasts, 2018 - 2030
目次
Product Code: GVR-4-68040-178-9

Arbovirus Testing Market Size & Trends:

The global arbovirus testing market size was valued at USD 1.12 billion in 2024 and is expected to grow at a CAGR of 4.5% from 2025 to 2030. The rising incidence of arboviral diseases such as Zika, dengue, and West Nile is fueling the demand for robust testing solutions. The increasing prevalence of these diseases in various regions has heightened the need for accurate diagnostics to manage outbreaks effectively. Increased awareness among the public and healthcare systems has led to improved surveillance efforts, enabling faster identification and response to potential outbreaks.

This greater focus on disease monitoring drives the arbovirus testing market, as governments and health organizations prioritize timely detection to control the spread of these infections.

Arbovirus testing has emerged as a pivotal tool in preventing the spread of these Neglected Tropical Diseases (NTDs). According to WHO estimates, around one-fifth of the population-about 1.7 billion people, mostly in developing and low-income nations-must receive diagnosis and treatment for at least one noncommunicable disease annually. The dengue and chikungunya NTD epidemic impacted almost 40% of Africa. These illnesses are more common in impoverished communities in tropical and hard-to-reach locations due to a favorable environment for virus growth and lack of hygiene. Thus, most NTD cases are reported from Brazil, Yemen, India, Bangladesh, China and several countries in Central and East Africa. Thus, the rising incidence of dengue and chikungunya is anticipated to fuel the demand for arbovirus testing, thereby driving market growth.

Moreover, several international organizations run programs to raise awareness of NTDs, including the United States Global Health Initiative, the Global NTD Program by the Centers for Disease Control and Prevention, the World Health Organization's Global NTD Programs, and the NTD Program by the United States Agency for International Development. These programs focus mainly on reducing or eliminating NTDs such as dengue and chikungunya. In addition, the WHO introduced a pilot program for a WHO Expert Review Panel for Diagnostic Products (ERPD) for NTDs in October 2023. This program focuses on enhancing the quality control and availability of NTD diagnostic tools for medical professionals.

Global Arbovirus Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global arbovirus testing market report on the basis of type, end-use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • ELISA-based Tests
  • RT-PCR Based Tests
  • Other Test Types
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Diagnostic Laboratories
  • Hospitals
  • Research Centers
  • Other End Use
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. End Use Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Scenario

Chapter 3. Arbovirus Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Arbovirus Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Arbovirus Testing Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Arbovirus Testing Market: Type Movement Analysis
  • 4.3. Global Arbovirus Testing Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
  • 4.4. ELISA-Based Tests
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. RT-PCR Based Tests
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6. Other Test Types
    • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Arbovirus Testing Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Arbovirus Testing Market: End Use Movement Analysis
  • 5.3. Global Arbovirus Testing Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 5.4. Diagnostic Laboratories
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Hospitals
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Research Centers
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Other End Use
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Arbovirus Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Arbovirus Testing Market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key Country Dynamics
      • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.1.3. Competitive Scenario
      • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Germany
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.1.3. Competitive Scenario
      • 6.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. U.K.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.6.3. Competitive Scenario
      • 6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.7.3. Competitive Scenario
      • 6.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.8.3. Competitive Scenario
      • 6.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.1.3. Competitive Scenario
      • 6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.4. South Korea
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.3.3. Competitive Scenario
      • 6.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.4.3. Competitive Scenario
      • 6.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.5.3. Competitive Scenario
      • 6.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/ Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key Company Heat Map Analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Abbott
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Thermo Fisher Scientific Inc.
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. NovaTec Immundiagnostica GmbH (Gold Standard Diagnostics Frankfurt GmbH)
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Agilent Technologies, Inc.
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. EUROIMMUN Medical Laboratory Diagnostics AG
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Merck KGaA
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. F. Hoffmann-La Roche Ltd
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Siemens Healthineers AG
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. QIAGEN
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Bio-Rad Laboratories, Inc.
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives